Acute and chronic inflammatory eye diseases are difficult to diagnose and maintain quiescent with therapy. Proposed study is aimed to find on the one hand, novel factors for recurrence of the disease or remission of inflammation and evaluation of the impact of lifestyle and known factors on the other. Each patient is treated in accordance to the best of medical knowledge and guidelines for each disease. This prospective cohort study will enroll uveitic patients to the steroid only group (SG), combined (steroid and adjuvant drug) group (CG) or bilogic therapy group (BTG). At baseline, patient data are recorded using patient-reported outcome measures and clinical assessments (ophthalomology) on disease activity (clinical scales), quality of life, and lifestyle together with registry data on comorbidity and medication. During follow-up evaluation of a successful treatment outcome response will be based on clinical scales and most frequently used primary endpoints; the major outcome of the analyses will be to detect differences in treatment outcome between patients in different treatment group.
Study Type
OBSERVATIONAL
Enrollment
300
Surveillance card and additional examination to find novel markers and better assess the existing ones
Department of Ophthalmology
Wroclaw, Poland
RECRUITINGTreatment success
Total number of treatment success in each group
Time frame: 1 year
Recurrence time
Time to the next recurrence after the treatment regimen introduction
Time frame: 10 years
Severe visual loss
Time and cause of severe visual loss
Time frame: 10 years
ETDRS Visual Acuity
Visual Acuity will be performed with ETDRS charts different for right and left eye
Time frame: 10 years
The SUN working group grading system for anterior chamber cells
At each visit anterior chamber will be examined to assess anterior chamber cells (1mm x 1mm slit beam in height and width, when thrown at an angle of 45-60°). The recorded number of cells will be used to determine the grade according to the SUN criteria.
Time frame: 10 years
The SUN working group grading system for anterior chamber flare
At each visit anterior chamber will be examined to assess anterior chamber flare (1mm x 1mm slit beam in height and width, when thrown at an angle of 45-60°). The observed changes will be used to determine the grade according to the SUN criteria.
Time frame: 10 years
AREDS 2008 Clinical Lens Opacity Grading Procedure
Using AREDS system for classifying cataracts from photographs: AREDS Report No. 4 the lens opacity will be graded.
Time frame: 10 years
NIH grading system for vitreous cells
At each visit vitreous will be examined to assess vitreous cells (1mm x 3mm slit beam in anterior vitreous). The recorded number of cells will be used to determine the grade according to the NIH criteria.
Time frame: 10 years
NIH grading system for vitreous haze
At each visit vitreous will be examined to assess vitreous haze. The recorded of clarity of posterior pole funduscopy will be used to determine the grade according to the NIH criteria.
Time frame: 10 years
Submacular choroidal thickness
OCT EDI recordings processed with developed by researchers methodology for image processing.
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.